The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tisotumab vedotin versus investigator’s choice chemotherapy in second- or third-line recurrent or metastatic cervical cancer (innovaTV 301/ENGOT-cx12/GOG 3057, trial in progress).
 
Ignace Vergote
Consulting or Advisory Role - Amgen (Inst); AstraZeneca; Carrick Therapeutics (Inst); Clovis Oncology (Inst); Deciphera (Inst); Elevar Therapeutics; Genmab (Inst); GlaxoSmithKline; Immunogen; Jazz Pharmaceuticals; Mersana; MSD; Novocure; Octimet (Inst); Oncoinvent; Roche; Sotio; Tesaro (Inst); Verastem (Inst); Zentalis
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Abbvie; Advaxis; Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Asymmetric Therapeutics; Boston Biomedical; ChemoID; Clovis Oncology; Deciphera; Eisai; Elevar Therapeutics; Geistlich Pharma; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Immunomedics; Incyte; Iovance Biotherapeutics; Iovance Biotherapeutics; Iovance Biotherapeutics; Karyopharm Therapeutics; Laekna Health Care; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Nucana; Oncomed; Oncoquest; Oncosec; Perthera; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Senti Biosciences; Starton Therapeutics; Takeda; Tarveda Therapeutics; TESARO/GSK; Vascular Biogenics; Vavotar Life Sciences; Vigeo Therapeutics
Consulting or Advisory Role - Abbvie; Advaxis; Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Asymmetric Therapeutics; Boston Biomedical; ChemoCare; Chemocare; ChemoID; Clovis Oncology; Deciphera; Eisai; Geistlich Pharma; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Immunomedics; Incyte; Iovance Biotherapeutics; Karyopharm Therapeutics; Laekna Health Care; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Nucana; Oncomed; Oncoquest; Oncosec; Perthera; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Senti Biosciences; Sorrento Therapeutics; Sorrento Therapeutics; Takeda; Tarveda Therapeutics; TESARO/GSK; Vascular Biogenics; Vavotar Life Sciences; Vigeo Therapeutics
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Merck; Roche/Genentech; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Robert L. Coleman
Employment - US Oncology
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche; Genmab; Immunogen; Novocure; Oncolytics; OncoMed; OncoSec; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merck; OncoMed; Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Leslie M. Randall
Honoraria - BluPrint Oncology; Curio Science; PER; Projects in Knowledge; Projects in Knowledge
Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; EMD Serono; Genentech/Roche; GOG Foundation; Merck; Mersana; Myriad Genetics; Novocure; Rubius Therapeutics
Speakers' Bureau - AstraZeneca; Merck; Tesaro
Research Funding - Aivita Biomedical (Inst); Akeso Biopharma (Inst); AstraZeneca (Inst); GEICO (Inst); Genentech/Roche (Inst); Merck (Inst); On Target Laboratories (Inst); Pfizer (Inst); Tesaro (Inst)
 
Keiichi Fujiwara
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Zeria Pharmaceutical
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; Genmab; MSD; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); Genmab (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); Lilly (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Regeneron (Inst); Shionogi (Inst); Zeria Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie; MSD; Pfizer
 
Christian Marth
Honoraria - AstraZeneca; GlaxoSmithKline; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Roche
 
Linn Lena Woelber
Honoraria - GlaxoSmithKline; Medac; MSD Oncology; Pfizer; promedicis; Roche; Tesaro; Teva
Consulting or Advisory Role - Genmab; Roche Molecular Diagnostics; Tesaro
Research Funding - Medac (Inst); Roche Molecular Diagnostics (Inst)
Travel, Accommodations, Expenses - Medac; Tesaro
 
Els Van Nieuwenhuysen
No Relationships to Disclose
 
David Cibula
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Roche; Sotio
 
Paula Calvert
Travel, Accommodations, Expenses - Ipsen; MSD Oncology; Novartis; Pfizer; Takeda
 
Ingrid Boere
Research Funding - Seagen
 
Antonio González-Martín
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Genmab; GlaxoSmithKline; Mersana; Roche
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche
Research Funding - GlaxoSmithKline; Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Roche
 
Elsa Kalbacher
Honoraria - AstraZeneca; LEO Pharma; Roche; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Roche; Tesaro/GSK
Travel, Accommodations, Expenses - AstraZeneca; LEO Pharma; Roche; Tesaro/GSK
 
Nicoletta Colombo
Honoraria - Amgen; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Immunogen; mersana; mersana; MSD Oncology; Novartis; Pfizer; Pfizer; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; Eisai; GlaxoSmithKline; Immunogen; mersana; MSD Oncology; Pfizer; Pfizer; PharmaMar; Roche/Genentech; Tesaro
 
Domenica Lorusso
Honoraria - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Merck Serono; MSD
Consulting or Advisory Role - PharmaMar
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD
Research Funding - Clovis Oncology (Inst); GlaxoSmithKline (Inst); MSD (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; GlaxoSmithKline; PharmaMar; Roche
 
Susana N. Banerjee
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Carrick Therapeutics (Inst); Clovis Oncology; GenMab; GlaxoSmithKline; Merck; Mersana; MSD Oncology; Roche; Tesaro
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Nucana
 
Fernando C. Maluf
Honoraria - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; Ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Sharp & Dohme
 
Ibrahima Soumaoro
Employment - Genmab
Stock and Other Ownership Interests - Bristol-Myers Squibb; Genmab
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genmab
 
Brian M. Slomovitz
Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; Eisai; Genentech; GlaxoSmithKline; GOG Foundation; Incyte; Merck; Myriad Genetics